Tuning the lipophilic nature of pyclen-based 90Y3+ radiopharmaceuticals for β-radiotherapy

Pyclen-dipicolinate chelates proved to be very efficient chelators for the radiolabeling with β--emitters such as 90Y. In this study, a pyclen-dipicolinate ligand functionalized with additional C12 alkyl chains was synthesized. The radiolabeling with 90Y proved that the addition of saturated carbon...

Full description

Saved in:
Bibliographic Details
Published inMetallomics Vol. 13; no. 12
Main Authors Le Fur, Mariane, Fougère, Olivier, Lepareur, Nicolas, Rousseaux, Olivier, Tripier, Raphaël, Beyler, Maryline
Format Journal Article
LanguageEnglish
Published England 10.12.2021
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:Pyclen-dipicolinate chelates proved to be very efficient chelators for the radiolabeling with β--emitters such as 90Y. In this study, a pyclen-dipicolinate ligand functionalized with additional C12 alkyl chains was synthesized. The radiolabeling with 90Y proved that the addition of saturated carbon chains does not affect the efficiency of the radiolabeling, whereas a notable increase in lipophilicity of the resulting 90Y radiocomplex was observed. As a result, the compound could be extracted in Lipiodol® and encapsulated in biodegrable pegylated poly(malic acid) nanoparticles demonstrating the potential of lipophilic pyclen-dipicolinate derivatives as platforms for the design of radiopharmaceuticals for the treatment of liver or brain cancers by internal radiotherapy.
ISSN:1756-591X
DOI:10.1093/mtomcs/mfab070